Pathophysiology and Clinical Implications of Cognitive Dysfunction in Fibromyalgia

Area of Science:

• Rheumatology
• Neuroscience
• Psychiatry

Background:

• Fibromyalgia is characterized by widespread pain, fatigue, and poor sleep, but cognitive dysfunction is a highly distressing and under-researched symptom.
• Cognitive complaints in fibromyalgia can be more debilitating than pain, negatively impacting patients' quality of life.
• Underestimation of cognitive symptoms by healthcare professionals leads to delayed diagnosis and management.

Purpose of the Study:

• To review the literature on the pathophysiology and risk factors of cognitive dysfunction in fibromyalgia.
• To identify recent treatment modalities and clinical implications for managing fibromyalgia-related cognitive dysfunction.
• To provide recommendations for screening, diagnosis, and management based on current research.

Main Methods:

• Traditional literature review of PubMed database.
• Focus on studies published within the last five years.
• Analysis of mechanisms, risk factors, treatments, and clinical recommendations.

Main Results:

• Cognitive dysfunction in fibromyalgia stems from various mechanisms, including pain perception, hormonal changes, and altered brain metabolites.
• Tobacco smoking and high body mass index were found to inversely impact cognitive dysfunction and quality of life.
• The review identified several risk factors and discussed clinical implications for diagnosis and management.

Conclusions:

• Cognitive dysfunction is a significant and complex symptom in fibromyalgia requiring greater clinical attention.
• Understanding the underlying mechanisms and risk factors is essential for effective management.
• Early screening, diagnosis, and tailored interventions can improve patient outcomes and quality of life.